|
FAM173B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.238700E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.443860E-03 |
| Normal-vs-Stage2 |
1.214390E-01 |
| Normal-vs-Stage3 |
2.464100E-02 |
| Normal-vs-Stage4 |
2.48529999999914E-05 |
| Stage1-vs-Stage2 |
8.091600E-01 |
| Stage1-vs-Stage3 |
8.188600E-01 |
| Stage1-vs-Stage4 |
5.803900E-02 |
| Stage2-vs-Stage3 |
7.464600E-01 |
| Stage2-vs-Stage4 |
2.631600E-01 |
| Stage3-vs-Stage4 |
3.661400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.056600E-03 |
| Normal-vs-AfricanAmerican |
3.453700E-02 |
| Normal-vs-Asian |
8.589200E-01 |
| Caucasian-vs-AfricanAmerican |
1.588030E-01 |
| Caucasian-vs-Asian |
8.190100E-02 |
| AfricanAmerican-vs-Asian |
2.663000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.775830E-04 |
| Normal-vs-Female |
2.366600E-01 |
| Male-vs-Female |
6.584300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.611900E-04 |
| Normal-vs-Extreme_Weight |
1.040220E-03 |
| Normal-vs-Obese |
2.308400E-02 |
| Normal-vs-Extreme_Obese |
3.947900E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.539000E-01 |
| Normal_Weight-vs-Obese |
2.809800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.949600E-01 |
| Extreme_Weight-vs-Obese |
3.008600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.756000E-01 |
| Obese-vs-Extreme_Obese |
6.535400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.301400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.297500E-03 |
| Normal-vs-Age(61-80Yrs) |
3.191100E-04 |
| Normal-vs-Age(81-100Yrs) |
1.952110E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.467200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.544350E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.800800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.058800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.475200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.189600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.721040E-03 |
| Normal-VS-Type2 PRCC |
2.283700E-03 |
| Normal-VS-KIRP CIMP |
1.641860E-03 |
| Normal-VS-Unclassified PRCC |
8.980400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.506200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.103600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.527600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.318200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.949200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.493780E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.039000E-03 |
| Normal-vs-N1 |
1.241020E-04 |
| Normal-vs-N2 |
8.680700E-03 |
| N0-vs-N1 |
3.692600E-01 |
| N0-vs-N2 |
3.646400E-01 |
| N1-vs-N2 |
4.307600E-01 |
|
|
